Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP07 - Pathology
- Type: Posters (Featured)
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 17
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP07.06 - Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.
00:00 - 00:00 | Author(s): Felix Blanc-Durand
- Abstract
Loading... -
+
FP07.11 - Circulating Tumor DNA (ctDNA) Clearance as a Biomarker in Patients With Locally Advanced NSCLC Following Chemoradiation
00:00 - 00:00 | Presenter: Brendan James Knapp
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P09 - Health Services Research/Health Economics - Real World Outcomes
- Type: Posters
- Track: Health Services Research/Health Economics
- Presentations: 60
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P09.15 - Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19
00:00 - 00:00 | Presenter: Laia Fernández-Mañas
- Abstract
Loading... -
+
P09.28 - Access to Intermediate and Intensive Care for Patients With Lung Cancer During the COVID-19 Period
00:00 - 00:00 | Presenter: Teresa Gorría
- Abstract
Loading...
-
+
P33 - Pathology - Immunotherapy Biomarker
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 22
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P33.10 - Identification of Long-Responders and Fast-Progressors under Immunotherapy Based on Early Monitoring of dNLR in Advanced NSCLC Patients
00:00 - 00:00 | Presenter: Mariona Riudavets
- Abstract
Loading...
-
+
P34 - Pathology - Liquid Biopsy
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 10
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P34.06 - The Clinical Utility of Liquid Biopsy by Digital Droplet PCR in Patients with Advanced NSCLC
00:00 - 00:00 | Presenter: Virginie Jeanine Lamberts
- Abstract
Loading...
-
+
P84 - Targeted Therapy - Clinically Focused - ALK
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 23
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P84.01 - The ARIA Study: Activity of Next-Generation ALK TKIs Based on ALK Resistance Mutations Detected by Liquid Biopsy in ALK Positive NSCLC Patients.
00:00 - 00:00 | Presenter: Laura Mezquita
- Abstract
Loading...
-
+
MA03 - New and Revisited Prognostic Factors in Early Stage Lung Cancer
- Type: Mini Oral
- Track: Early Stage/Localized Disease
- Presentations: 13
- Coordinates: 1/29/2021, 15:30 - 16:30, Scientific Program Auditorium
-
+
MA03.08 - Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer
15:55 - 16:00 | Presenter: Roxana Reyes
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA07 - Immuno-biology and Novel Immunotherapeutics from Bench to Bed
- Type: Oral
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
- Presentations: 11
- Coordinates: 1/30/2021, 10:30 - 11:30, Scientific Program Auditorium
-
+
OA07.10 - Discussant
11:15 - 11:20 | Presenter: Laura Mezquita
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA08 - Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma
- Type: Mini Oral
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 13
- Coordinates: 1/30/2021, 16:45 - 17:45, Scientific Program Auditorium
-
+
MA08.04 - LIPI and Outcomes of Durvalumab as Consolidation Therapy after ChRT in Patients with Locally-Advanced NSCLC
16:50 - 16:55 | Presenter: Mariona Riudavets
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
